Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 32.26% is in line with its 1-year average of 35.47%, near the low end of its 1-year range (30.63%–39.63%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.84% below its 12-month average of 34.64%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 32.26%.
DEBT TO ASSETS RATIO
32.26%
DEBT TO ASSETS RATIO AVG TTM
34.64%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-6.84%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+35749.97%
vs the sector median at left
Park Dental Partners, Inc. Common Stock
Market Cap
$94.32M
Debt to Assets Ratio
32.26%
TTM Avg
34.64%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.10M
Debt to Assets Ratio
0.78%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$91.25M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$91.10M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.11M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $94.32M | 32.26% | 34.64% | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.10M | 0.78% | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $91.36M | 0.01% | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $91.25M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $91.10M | 0.02% | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.71M | 0.10% | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $98.14M | 0.26% | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $90.11M | 0.00% | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $89.89M | 0.56% | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.56M | 0.27% | N/A | N/A | N/A |
Debt/Assets
32.3%
Debt/Equity
2.02
Current Ratio
1.12
Interest Coverage
2.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 32.26% |
| 2026-03-31 | 33.22% |
| 2025-12-31 | 30.63% |
| 2025-09-30 | 37.44% |
| 2025-06-30 | 39.63% |
| 2025-03-31 | 39.63% |
